AI brief of an SEC Form 8-K · Parabilis Medicines, Inc. (PBLS)

Parabilis Medicines amends Cambridge headquarters lease, extends term to 2037

Neutral Impact 2 of 5 product/contract Written later

Parabilis Medicines entered into a Third Amendment to its lease for its Cambridge, Massachusetts headquarters, adding 33,525 square feet of space at the neighboring 20 Acorn Park Drive and extending the lease term through December 31, 2037. The filing describes this as a lease change, and it does not state any financial effect on the company's results.

Key points

  • Amendment dated October 30, 2026, with LS 400/500 CDP, LLC, amends the 2019 headquarters lease.
  • Expansion of 33,525 square feet on the first and sixth floors of 20 Acorn Park Drive begins January 1, 2028, with rent commencing January 1, 2029.
  • Lease extension term runs from March 1, 2031 to December 31, 2037, with eight months of base rent abatement subject to conditions.
  • The company gets an option to extend the lease for two additional five-year periods.

The filing

CompanyParabilis Medicines, Inc. (PBLS)
Form8-K, current report
Filed with the SECNov 5, 2026, 4:15 PM ET
Accession number0001193125-26-449869

Items reported: 1.01 Material Definitive Agreement

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:53 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 05, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.